Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Livermore

Showing results (41-50 of 245) with videos related to

Pageof 25
Sort By:
The Journal of Antimicrobial Chemotherapy|March 1, 1989
Interactions of FCE 22101 with class I beta-lactamasesY Yang, D M Livermore
Journal of Medical Microbiology|October 1, 1988
Mechanisms of chloramphenicol resistance in Haemophilus influenzae in the United KingdomM Powell, D M Livermore
Diagnostic Microbiology and Infectious Disease|July 1, 1994
Inoculum effects on Etests and agar dilution minimum inhibitory concentrations. Piperacillin and piperacillin-tazobactam against Staphylococcus aureusG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|December 1, 1990
Selection and transformation of non-beta-lactamase-mediated insusceptibility to beta-lactams in Haemophilus influenzae: lack of cross-resistance between carbapenems and other agentsM Powell, D M Livermore
The Journal of Antimicrobial Chemotherapy|September 1, 1993
Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinationsG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|December 1, 1991
Effect of media composition on the susceptibility of Xanthomonas maltophilia to beta-lactam antibioticsG Bonfiglio, D M Livermore
Lancet (London, England)|January 15, 2000
Quinupristin/dalfopristin, a new addition to the antimicrobial arsenalA P Johnson, D M Livermore
The Journal of Antimicrobial Chemotherapy|December 1, 1981
In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamasesD M Livermore, J D Williams
The Journal of Antimicrobial Chemotherapy|July 12, 2005
CTX-M: changing the face of ESBLs in the UKD M Livermore, P M Hawkey
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Penicillin-binding protein (PBP) 2 and the post-antibiotic effect of carbapenemsP A Majcherczyk, D M Livermore
Pageof 25

Showing results (41-50 of 245) with videos related to

Sort By:
Pageof 25
The Journal of Antimicrobial Chemotherapy|March 1, 1989
Interactions of FCE 22101 with class I beta-lactamasesY Yang, D M Livermore
Journal of Medical Microbiology|October 1, 1988
Mechanisms of chloramphenicol resistance in Haemophilus influenzae in the United KingdomM Powell, D M Livermore
Diagnostic Microbiology and Infectious Disease|July 1, 1994
Inoculum effects on Etests and agar dilution minimum inhibitory concentrations. Piperacillin and piperacillin-tazobactam against Staphylococcus aureusG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|December 1, 1990
Selection and transformation of non-beta-lactamase-mediated insusceptibility to beta-lactams in Haemophilus influenzae: lack of cross-resistance between carbapenems and other agentsM Powell, D M Livermore
The Journal of Antimicrobial Chemotherapy|September 1, 1993
Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinationsG Bonfiglio, D M Livermore
The Journal of Antimicrobial Chemotherapy|December 1, 1991
Effect of media composition on the susceptibility of Xanthomonas maltophilia to beta-lactam antibioticsG Bonfiglio, D M Livermore
Lancet (London, England)|January 15, 2000
Quinupristin/dalfopristin, a new addition to the antimicrobial arsenalA P Johnson, D M Livermore
The Journal of Antimicrobial Chemotherapy|December 1, 1981
In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamasesD M Livermore, J D Williams
The Journal of Antimicrobial Chemotherapy|July 12, 2005
CTX-M: changing the face of ESBLs in the UKD M Livermore, P M Hawkey
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Penicillin-binding protein (PBP) 2 and the post-antibiotic effect of carbapenemsP A Majcherczyk, D M Livermore
Pageof 25